<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10225377" created="22/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10225377</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Activation of <term id="T1" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term> by <term id="T2" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> in <term id="T3" lex="mononuclear_leukocyte" sem="Cell_natural">mononuclear leukocytes</term> is prevented by <term id="A1" sem="Other">inhibitors of <term id="T4" lex="cytosolic_phospholipase_A2" sem="Protein_molecule">cytosolic phospholipase A2</term></term>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="T1"/>
<cause idref="T2"/>
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> nuclear factor-kappaB <linkCause>by</linkCause> lipopolysaccharide <clueLoc>in mononuclear leukocytes</clueLoc> is prevented by inhibitors of cytosolic phospholipase A2.</clue>
<comment>TPS A1</comment></event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="A1"/>
<clue>Activation of nuclear factor-kappaB by lipopolysaccharide in mononuclear leukocytes is <clueType>prevented</clueType> <linkCause>by</linkCause> inhibitors of cytosolic phospholipase A2.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In <term id="T5" lex="monocyte" sem="Cell_natural">monocytes</term>, <term id="T6" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> induces synthesis and activity of the 85-kDa <term id="T7" lex="cytosolic_phospholipase_A2" sem="Protein_molecule">cytosolic phospholipase A2</term>.</sentence>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T7"/>
<clue>In monocytes, lipopolysaccharide induces <clueType>synthesis</clueType> and activity <linkTheme>of</linkTheme> the 85-kDa cytosolic phospholipase A2.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T6"/>
<clue><clueLoc>In monocytes</clueLoc>, lipopolysaccharide <clueType>induces</clueType> synthesis and activity of the 85-kDa cytosolic phospholipase A2.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="T6"/>
<clue><clueLoc>In monocytes</clueLoc>, lipopolysaccharide <clueType>induces</clueType> synthesis and activity of the 85-kDa cytosolic phospholipase A2.</clue>
</event>
<sentence id="S3">This enzyme releases <term id="T8" lex="arachidonic_acid" sem="Organic_compound_other">arachidonic acid</term> and <term id="T9" lex="lyso-phospholipid" sem="Lipid">lyso-phospholipids</term> from membranes which are metabolized to <term id="T10" lex="eicosanoid" sem="Organic_compound_other">eicosanoids</term> and <term id="T11" lex="platelet-activating-factor" sem="Organic_compound_other">platelet-activating-factor</term>.</sentence>
<event KT="Fact" id="E6">
<type class="Localization"/>
<theme idref="T8"/>
<theme idref="T9"/>
<clue>This enzyme <clueType>releases</clueType> arachidonic acid and lyso-phospholipids <clueLoc>from membranes</clueLoc> which are metabolized to eicosanoids and platelet-activating-factor.</clue>
</event>
<event KT="Fact" id="E107">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T7"/>
<clue><corefCause>This enzyme</corefCause> <clueType>releases</clueType> arachidonic acid and lyso-phospholipids from membranes which are metabolized to eicosanoids and platelet-activating-factor.</clue>
</event>
<event KT="Fact" id="E7">
<type class="Metabolism"/>
<theme idref="T8"/>
<theme idref="T10"/>
<clue>This enzyme releases arachidonic acid and lyso-phospholipids from membranes <corefTheme>which</corefTheme> are <clueType>metabolized</clueType> <linkTheme>to</linkTheme> eicosanoids and platelet-activating-factor.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Metabolism"/>
<theme idref="T9"/>
<theme idref="T11"/>
<clue>This enzyme releases arachidonic acid and lyso-phospholipids from membranes <corefTheme>which</corefTheme> are <clueType>metabolized</clueType> <linkTheme>to</linkTheme> eicosanoids and platelet-activating-factor.</clue>
</event>
<sentence id="S4">These lipid mediators increase activity of <term id="T12" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> and expression of <term id="T13" lex="cytokine_gene" sem="DNA_family_or_group">cytokine genes</term> indicating a function for <term id="T14" lex="cytosolic_phospholipase_A2" sem="Protein_molecule">cytosolic phospholipase A2</term> in <term id="T15" lex="signal_transduction" sem="Other">signal transduction</term> and <term id="T16" lex="inflammation" sem="Other">inflammation</term>.</sentence>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue>These lipid mediators increase activity of transcription factors and <clueType>expression</clueType> <linkTheme>of</linkTheme> cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event KT="Fact" id="E10">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T10"/>
<clue><corefCause>These lipid mediators</corefCause> <clueType>increase</clueType> activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T11"/>
<clue><corefCause>These lipid mediators</corefCause> <clueType>increase</clueType> activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T10"/>
<clue><corefCause>These lipid mediators</corefCause> <clueType>increase</clueType> activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event KT="Fact" id="E13">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T11"/>
<clue><corefCause>These lipid mediators</corefCause> <clueType>increase</clueType> activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E14">
<type class="Regulation"/>
<theme idref="T15"/>
<cause idref="T14"/>
<clue>These lipid mediators increase activity of transcription factors and expression of cytokine genes <clueKT><clueCL>indicating</clueCL></clueKT> a <clueType>function</clueType> <linkCause>for</linkCause> cytosolic phospholipase A2 <linkTheme>in</linkTheme> signal transduction and inflammation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E15">
<type class="Regulation"/>
<theme idref="T16"/>
<cause idref="T14"/>
<clue>These lipid mediators increase activity of transcription factors and expression of cytokine genes <clueKT><clueCL>indicating</clueCL></clueKT> a <clueType>function</clueType> <linkCause>for</linkCause> cytosolic phospholipase A2 <linkTheme>in</linkTheme> signal transduction and inflammation.</clue>
</event>
<sentence id="S5">We have shown previously that <term id="A3" sem="Organic_compound_other"><term id="T17" lex="trifluoromethylketone_inhibitor" sem="Organic_compound_other">trifluoromethylketone inhibitors</term> of <term id="T18" lex="cytosolic_phospholipase_A2" sem="Protein_molecule">cytosolic phospholipase A2</term></term> suppressed <term id="T19" lex="interleukin-1beta_protein" sem="Protein_molecule">interleukin-1beta</term> <term id="A2" sem="Protein_molecule">protein</term> and <term id="T20" lex="steady-state_mRNA_level" sem="RNA_molecule">steady-state mRNA</term> levels in human <term id="T21" lex="lipopolysaccharide-stimulated_peripheral_blood_mononuclear_leukocyte" sem="Cell_natural"><term id="T22" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term>-stimulated peripheral blood <term id="T23" lex="mononuclear_leukocyte" sem="Cell_natural">mononuclear leukocytes</term></term>.</sentence>
<event KT="Analysis" Source="Other" id="E16">
<type class="Negative_regulation"/>
<theme idref="T19" idref1="A2"/>
<cause idref="A3"/>
<clue>We have <clueKT>shown</clueKT> <clueSource>previously</clueSource> that trifluoromethylketone inhibitors of cytosolic phospholipase A2 <clueType>suppressed</clueType> interleukin-1beta protein and steady-state mRNA levels <clueLoc>in human lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes</clueLoc>.</clue>
<comment>NER T19 mod, TPS A3</comment></event>
<event KT="Analysis" Source="Other" id="E17">
<type class="Negative_regulation"/>
<theme idref="T19" idref1="T20"/>
<cause idref="A3"/>
<clue>We have <clueKT>shown</clueKT> <clueSource>previously</clueSource> that trifluoromethylketone inhibitors of cytosolic phospholipase A2 <clueType>suppressed</clueType> interleukin-1beta protein and steady-state mRNA levels <clueLoc>in human lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes</clueLoc>.</clue>
<comment>NER T20 mod</comment></event>
<sentence id="S6">In this study, the <term id="T24" lex="subcellular_mechanism" sem="Other">subcellular mechanisms</term> were analyzed by which <term id="T25" lex="trifluoromethylketone" sem="Organic_compound_other">trifluoromethylketones</term> interfere with <term id="T26" lex="gene_expression" sem="Other">gene expression</term>.</sentence>
<event KT="Investigation" id="E18">
<type class="Negative_regulation"/>
<theme idref="T26"/>
<cause idref="T25"/>
<clue>In this study, the subcellular mechanisms were <clueKT>analyzed</clueKT> by which trifluoromethylketones <clueType>interfere</clueType> <linkTheme>with</linkTheme> gene expression.</clue>
<comment>NER T26 mod</comment></event>
<sentence id="S7">We found that they reduced the initial <term id="T27" lex="interleukin-1beta_mRNA_transcription" sem="Other"><term id="T28" lex="interleukin-1beta_mRNA" sem="RNA_family_or_group">interleukin-1beta mRNA</term> transcription</term> rate through prevention of degradation of <term id="T29" lex="inhibitor-kappaB_alpha" sem="Protein_molecule">inhibitor-kappaB alpha</term>.</sentence>
<event KT="Other" id="E19">
<type class="Protein_catabolism"/>
<theme idref="T29"/>
<clue>We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of <clueType>degradation</clueType> <linkTheme>of</linkTheme> inhibitor-kappaB alpha.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="T25"/>
<cause idref="E12"/>
<clue>We found that <corefCause>they</corefCause> <clueType>reduced</clueType> the initial interleukin-1beta mRNA transcription rate <clueType>through prevention</clueType> <linkTheme>of</linkTheme> degradation of inhibitor-kappaB alpha.</clue>
</event>
<event id="E21">
<type class="Transcription"/>
<theme idref="T28"/>
<clue>We found that they reduced the initial interleukin-1beta mRNA <clueType>transcription</clueType> rate through prevention of degradation of inhibitor-kappaB alpha.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="E20"/>
<clue>We <clueKT>found</clueKT> that they <clueType>reduced</clueType> the initial interleukin-1beta mRNA transcription rate <linkCause>through</linkCause> prevention of degradation of inhibitor-kappaB alpha.</clue>
</event>
<sentence id="S8">Consequently, <term id="T30" lex="cytosolic_activation" sem="Other">cytosolic activation</term>, <term id="T31" lex="nuclear_translocation" sem="Other"><term id="T40" sem="Cell_component">nuclear</term> translocation</term> and <term id="A4" sem="DNA_domain_or_region">DNA</term>-binding of <term id="T32" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term> were decreased.</sentence>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<clue>Consequently, <clueLoc>cytosolic</clueLoc> <clueType>activation</clueType>, nuclear translocation and DNA-binding <linkTheme>of</linkTheme> nuclear factor-kappaB were decreased.</clue>
</event>
<event id="E24">
<type class="Localization"/>
<theme idref="T32"/>
<clue>Consequently, cytosolic activation, <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> and DNA-binding <linkTheme>of</linkTheme> nuclear factor-kappaB were decreased.</clue>
</event>
<event id="E25">
<type class="Binding"/>
<theme idref="A4"/>
<theme idref="T32"/>
<clue>Consequently, cytosolic activation, nuclear translocation and DNA-<clueType>binding</clueType> <linkTheme>of</linkTheme> nuclear factor-kappaB were decreased.</clue>
</event>
<event KT="Analysis" id="E26">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E22"/>
<clue><linkCause><clueKT>Consequently</clueKT></linkCause>, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were <clueType>decreased</clueType>.</clue>
</event>
<event KT="Analysis" id="E27">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E22"/>
<clue><linkCause><clueKT>Consequently</clueKT></linkCause>, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were <clueType>decreased</clueType>.</clue>
</event>
<event KT="Analysis" id="E28">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E22"/>
<clue><linkCause><clueKT>Consequently</clueKT></linkCause>, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were <clueType>decreased</clueType>.</clue>
</event>
<sentence id="S9"><term id="T33" lex="Trifluoromethylketone" sem="Organic_compound_other">Trifluoromethylketones</term> ameliorate chronic <term id="T35" lex="inflammation" sem="Other">inflammation</term> in vivo.</sentence>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="T35"/>
<cause idref="T33"/>
<clue>Trifluoromethylketones <clueType>ameliorate</clueType> chronic inflammation in vivo.</clue>
</event>
<sentence id="S10">Thus, this therapeutic potency may reside in retention of inactive <term id="T36" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term> in the <term id="T37" lex="cytosol" sem="Cell_natural">cytosol</term> thereby abrogating <term id="T38" lex="interleukin-1beta_gene_transcription" sem="Other"><term id="T39" lex="interleukin-1beta" sem="DNA_domain_or_region">interleukin-1beta gene</term> transcription</term>.</sentence>
<event CL="L1" KT="Analysis" id="E30">
<type class="Localization"/>
<theme idref="T36"/>
<clue><clueKT>Thus</clueKT>, this therapeutic potency <clueCL>may</clueCL> reside in <clueType>retention</clueType> of inactive nuclear factor-kappaB <clueLoc>in the cytosol</clueLoc> thereby abrogating interleukin-1beta gene transcription.</clue>
</event>
<event KT="Other" id="E31">
<type class="Transcription"/>
<theme idref="T39"/>
<clue>Thus, this therapeutic potency may reside in retention of inactive nuclear factor-kappaB in the cytosol thereby abrogating interleukin-1beta gene <clueType>transcription</clueType>.</clue>
<comment>NER T39 mod</comment></event>
<event KT="Analysis" id="E32">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="E30"/>
<clue>Thus, this therapeutic potency may reside in retention of inactive nuclear factor-kappaB in the cytosol <linkCause><clueKT>thereby</clueKT></linkCause> <clueType>abrogating</clueType> interleukin-1beta gene transcription.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
